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Purpose: This study evaluated the values of transcutaneous oxygen tension (TcPO2) measurement in diabetic patients
compared with nondiabetic patients and assessed its reproducibility.
Methods: In 60 diabetic patients (type 1 and type 2 diabetes mellitus) without signs of peripheral arterial disease or
neuropathy, we measured TcPO2 at the chest and foot and compared these measurements with 60 age- and sex-matched
nondiabetic patients in a cross-sectional fashion. The reproducibility of TcPO2 in terms of interobserver variability was
also assessed.
Results: Diabetic patients had a mean  SD TcPO2 value at the foot of 50.02  8.92 mm Hg, which was significantly lower
compared with 56.04  8.80 mm Hg in nondiabetic patients (P < .001). At the chest wall, values for TcPO2 were 51.77 
11.15 mm Hg, and 58.22 12.47 mm Hg for diabetic patients and nondiabetic patients, respectively (P .003). Regression
analysis showed that TcPO2was significantly associated with diabetes mellitus (coefficient  –0.258; P  .004), and with
having a first-degree relative with diabetes mellitus (coefficient –0.265;P .003). Furthermore, the interobserver variability
showed a substantial correlation for both measurements at the chest (P < .001; r  0.654; intraclass correlation coefficient
[ICC]  0.79) and at the dorsum of the foot (P < .001; r  0.426; ICC  0.60).
Conclusion:Diabetic patients without signs of peripheral disease or neuropathy had significantly lower TcPO2 values compared
with age- and sex-matched nondiabetic patients. The influence of the examiner on the variance in TcPO2 measurements was
relatively small. We advocate the use of TcPO measurement in diabetic patients to detect subclinical microvascular impairment2
as an additional tool to assess peripheral vascular disease. (J Vasc Surg 2008;48:382-8.)Transcutaneous oxygen tension (TcPO2) measure-
ment is a noninvasive diagnostic study that provides
information about the supply and delivery of oxygen to
the underlying microvascular circulation by recording
the partial pressure of oxygen at the skin surface. The
amount of oxygen detected by the sensor is a balance of
oxygen delivery and local physiologic demands and re-
flects the metabolic status of the skin.1 The TcPO2
measurement is used in determining amputation level,2,3
wound healing evaluation,4 hyperbaric therapy,5 and
peripheral arterial disease assessment,6,7 including the
status of spinal cord stimulation8 and revascularization
procedures.3,9,10
In the literature, a commonly accepted reference value
with TcPO2measurement for the diagnosis of peripheral
arterial disease is approximately 60 mm Hg, regardless of
electrode location.7,11,12 For wound healing to occur,
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382studies found that the TcPO2 should be 40 mm Hg, and
impaired wound healing is noted with values between 20
and 40 mm Hg. Failure of wound healing is demonstrated
with TcPO2values of 20 mm Hg.
13,14
The most appropriate clinical role for TcPO2 measure-
ment is to assist in the assessment of severe ischemia. Because
themeasurements are not affected by arterial calcification, it is
particularly useful in evaluating diabetic vascular disease. For
diabetic patients, however, TcPO2 values might not be the
same as for nondiabetic patients because potential subclinical
microangiopathy may cause alterations in capillary flow. The
use of the TcPO2measurement in the diabetic population has
been studied previously,4,15,16 but consistent reference values
for diabetic patients without signs of peripheral arterial disease
or neuropathy are lacking. With the increasing prevalence of
obesity, themetabolic syndrome, and associated diabetesmel-
litus (diabetes), and previous studies reporting that tissue
oxygenation measured by TcPO2 in patients with diabetes is
impaired,17,18 determining a reference value for TcPO2 in the
diabetic population could be of help in clinical daily practice.
This study evaluated the reference value for TcPO2
measurement in diabetic patients compared with nondi-
abetic patients and secondarily assessed the reproducibil-
ity of TcPO2in terms of interobserver variability.
METHODS
Study design and patients. We performed a cross-
sectional study at the Ikazia Hospital Rotterdam, The
Netherlands, a large community hospital with a specialized
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eases. The study included 60 diabetic patients (types 1 or 2)
from our outpatient clinic with diagnosed diabetes for at
least 1 year and without signs of peripheral arterial disease
and neuropathy. Selection criteria were on the basis of the
medical history, a comprehensive interview, and levels of
fasting blood glucose and glycosylated hemoglobin
(HbA1C). Also invited to participate in the study were 60
nondiabetic patients to match for age and sex.
A physical examination including palpation of the pedal
pulses, vibration thresholds, and standard fiber testing was
used to exclude peripheral arterial disease, injury to the
extremities, peripheral neuropathy and spinal conditions,
cardiovascular disease, pulmonary disease, and psychiatric
illness. Further evaluation of study participants considered
age, sex, height, weight, body mass index (BMI), smoking
habits, family history of diabetes, and if appropriate, type of
diabetes, type of medication, and diabetes duration.
The study was approved by the local ethics committee,
and was performed according to the declaration of Hel-
sinki.19 In accordance with institutional guidelines, written
informed consent to be part of this study and for their study
data to be reported in the literature for the purpose of
scientific articles was obtained from all patients before their
participation.
Measurement of TcPO2. A Radiometer TCM400
(Copenhagen, Denmark) TcPO2 monitor was used to si-
multaneously measure the TcPO2 values at the chest and at
the dorsum of the foot. The laboratory room temperature
was maintained at approximately 25°C. All patients accli-
matized for a minimum of 10 minutes before commencing
the study, during which the device was calibrated at 159
mmHg according to the manufacturer’s guidelines.20 The
measurements were simultaneously performed on one ran-
domly chosen lower extremity by two different vascular
technologists with the patient resting in supine position
during one session, each applying one electrode at the
dorsum of the foot and one reference at the thorax. The
reported values represent averages of the measurements
assessed by both observers.
At the measured site, skin was shaved and cleaned with
alcohol. A self-adhesive ring was filled with a buffered
solution, both supplied by the manufacturer, and the elec-
trode, heated to a temperature of 43°C, was attached. The
electrode at the dorsum of the foot was placed between the
first and second metatarsal heads just proximal to the first
and second toe, not over a visible vein, bony, or tendon
structure. The electrode at the chest was placed by the same
observer on the ipsilateral anterior chest wall at the midcla-
vicular line and infraclavicular fossa. The TcPO2 value was
recorded for analysis after obtaining a stable reading after
20 minutes. Three registered vascular technologists were
involved, all experienced in TcPO2 measurement.
Statistical analysis. All continuous variables were ex-
pressed asmeans standard deviation (SD). Significance of
differences between the group means was assessed by using
the Student t test, or if nonparametric, by using the Mann-
Whitney U test. Significant differences between nominaland categoric variables were assessed by using Fisher’s exact
test. A one-way sensitivity analysis was performed to test
whether TcPO2measurements80mmHg had influenced
the results. A subgroup analysis stratifying for type 1 and
type 2 diabetes was performed within the group of diabetic
patients. We then compared the subgroups of type 1 and
type 2 diabetic patients separately with the group of non-
diabetic patients. Backward multiple linear regression anal-
ysis was used to determine which factors were significantly
associated with TcPO2.
Data from both observers were plotted using Bland-
Altman graphs enabling an appreciation of the distribution
of error.21 Typical error was calculated using the SD of the
differences.22 The interobserver variability was assessed by
using the Pearson correlation coefficient. However, be-
cause our data include more than one observation on each
individual and outliers were present, the intraclass correla-
tion coefficient (ICC) was calculated as well, using a two-
way mixed-effects model with absolute agreement defini-
tion. The ICC is defined as the proportion of variance of an
observation due to between-subject variability in the true
scores and can be interpreted as poor (ICC 0.20), fair
(0.20 to 0.40), moderate (0.40 to 0.60), substantial
(0.60 to 0.80), and almost perfect (0.80 to 1.00).23,24
Significance was determined at a two-sided P .05 and
expressed with the 95% confidence interval (CI). All data
were collected in an Excel database (Microsoft Inc, Belling-
ham, Wash). The analysis was performed using SPSS 12.1
software (SPSS Inc, Chicago, Ill).
RESULTS
The study included 60 diabetic patients and 60 nondi-
abetic patients matched for age and sex. Demographics and
clinical characteristics of this study population are reported
in Table I. Smoking habits, defined as current or never/
ever (1 year) were equally distributed among diabetic
patients and nondiabetic patients (13 of 60 vs 10 of 60; P
.643; Table I). Significantly more diabetic patients had a
first-degree relative whowas diagnosed with diabetes (36 vs
21;P .010) but had a lower BMI (27.20 5.73 vs 30.21
6.25 kg/m2; t  2.74118, P  .007) compared with the
nondiabetic patients (Table I). Within the diabetic patients,
however, positive family history of diabetes (13 of 25 vs 23
of 35; P  .293) and BMI (t  2.1458 P  .487) were
equally distributed between type 1 and type 2 diabetic
patients (26.59  3.77 and 27.64  6.81 kg/m2, respec-
tively).
Fig 1 illustrates the mean values and corresponding
95% CI for TcPO2 for diabetic and nondiabetic patients:
The averaged mean values for TcPO2 measurements (mm
Hg) were, respectively, 50.02 8.92 and 56.04 8.80 at
the dorsum of the foot and 51.77  11.15 and 58.22 
12.47 at the chest wall. When diabetic and nondiabetic
patients were compared, the absolute difference of TcPO2
valuesmeasured at the foot and chest were 6.02mmHg (95%
CI, 2.81-9.22; P  .001) and 6.45 mm Hg (95% CI, 2.17-
10.73; P  .003), respectively. The absolute differences for
TcPO2 values between type 1 and type 2 diabeticsmeasured at
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.153), and 2.18 mm Hg (95% CI, –3.68 to 8.05; P  .459)
and showed no significant difference.
After comparing nondiabetic patients with type 2 dia-
betic patients, however, both the values for TcPO2 mea-
sured at the dorsum of the foot and chest wall were signif-
icantly different, with absolute differences of 7.41 mm Hg
(95% CI, 3.68–11.15; P  .001), and 7.36 mm Hg (95%
Table 1. Comparison of demographics and clinical charac
Demographic Diabe
Patients, No.
Type of diabetes, No.
Type 1
Type 2
Age, mean  SD, y
Overall 58.1
Type 1 48.7
Type 2 64.8
Age at diabetes diagnosis, y
Type 1 27.1
Type 2 56.0
Sex, No. (%)
Male 2
Female 3
Smoking habit, No. (%)
Yes 1
No/former 4
Family history of diabetes, No. (%)c
Yes 3
No 2
BMI, mean  SD kg/m2 27.2
Fasting blood glucose, mean  SD mmol/L 8.9
HbA1c, % 7.7
BMI, Body mass index; NA, not applicable; SD, standard deviation.
aStudent’s t test.
bFisher’s exact test.
cFamily history of diabetes mellitus in a first-degree relative.
dMann-Whitney U test.
Fig 1. Mean values and corresponding 95% confiden
(TcPO2)measured in mmHg at the (A) chest wall and (
patients.CI, 2.41–12.31; P  .004), respectively. The absolutedifferences for TcPO2 between nondiabetic patients and those
with type 1 diabetes were 5.18 mm Hg (95% CI, –0.72 to
11.07; P .084) for TcPO2 values measured at the chest and
4.06 mmHg (95% CI, –0.10 to 8.22; P .056) at the foot,
not reaching statistical significance.
Backward stepwise multiple linear regression analysis
showed that TcPO2was significantly associated with diabe-
tes (coefficient  –0.258; P  .004) and with having a
ics of diabetic patients and nondiabetic patients
tients Nondiabetic patients P
60
NA NA
NA NA
4.9 57.2  14.7 .756a
5.1 NA NA
0.5 NA NA
5.3 NA NA
0.4 NA NA
) 24 (40) 1.000b
) 36 (60)
) 10 (17) .643b
) 50 (83)
) 21 (35) .010b
) 39 (65)
.73 30.2  6.25 .007a
.9 5.4  0.9 .001d
.3 NA NA
tervals are shown for transcutaneous oxygen tension
orsum of the foot for diabetic patients and nondiabeticterist
tic pa
60
25
35
 1
 1
 1
 1
 1
4 (40
6 (60
3 (22
7 (78
6 (60
4 (40
 5
 2
 1ce in
B) dfirst-degree relative with diabetes (coefficient  –0.265;
95%
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duration of diabetes showed no significant associations
with TcPO2.
Interobserver variability. Table II reports the mean
values and corresponding 95% CI for TcPO2 for diabetic
and nondiabetic patients as recorded by the different ob-
servers. The absolute differences for TcPO2 between ob-
servers measured at the chest wall were 1.067 mmHg (95%
CI, –2.20 to 4.33; P  .516) for diabetic patients and
–0.733 mm Hg (95% CI, –3.29 to 1.83; P  .568) for
nondiabetic patients. At the dorsum of the foot, the abso-
lute differences for the TcPO2 measurement between ob-
servers were –0.117 (95% CI, -2.59 to 2.35; P .925) for
diabetic patients and –0.283 (95% CI, –3.86 to 3.29; P 
.875) for nondiabetic patients (Table II).
The results related to the Bland-Altman analyses
Table II. Mean values for transcutaneous oxygen tension
different observers
Location Patient Observer No.
Chest Nondiabetic Observer 1 60
Observer 2 60
Diabetic Observer 1 60
Observer 2 60
Foot Nondiabetic Observer 1 60
Observer 2 60
Diabetic Observer 1 60
Observer 2 60
CI, confidence interval.
aStudent’s t test.
Fig 2. The Bland-Altman distribution shows the diff
observer 1 and 2, with the average of TcPO2 in mm Hg
shows the mean difference and the dotted lines show theshow that the distribution of the error was low and,although outliers were present, randomly distributed
across the range of values for TcPO2 measured at the
dorsum of the foot and chest wall (Fig 2). After a
one-way sensitivity analysis by censoring the outlying
TcPO2 values80 mmHg (7 of 480 individual measure-
ments), the results did not change substantially. Fig 3
presents the correlation of TcPO2 values between ob-
server 1 and 2 for values measured at the chest wall (Fig
3, A) and dorsum of the foot (Fig 3, B). The values for
TcPO2 measured by the different observers at the chest
wall and dorsum of the foot were both positively corre-
lated (r  0.654; P  .001, and r  0.426; P  .001,
respectively). The ICC describing the interobserver vari-
ation was 0.79 (95% CI, 0.69-0.89; P  .001) for all
TcPO2 measurements at the chest wall and 0.60 (95% CI,
0.42-0.72; P  .001) for all TcPO2 measurements at the
abetic patients and nondiabetic patients measured by two
Mean 95% CI Difference Pa
57.85 54.16-61.54 0.733 .568
58.58 55.51-61.65
52.30 48.76-55.84 1.067 .516
51.23 48.31-54.15
55.90 52.76-59.04 0.283 .875
56.18 53.69-58.67
49.97 47.64-52.30 0.117 .925
50.08 47.31-52.85
e in transcutaneous oxygen tension (TcPO2) between
he (A) chest and (B) foot measurements. The solid line
confidence interval.in dierenc
for tdorsum of the foot.
e foo
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This study assessed mean values for TcPO2 measure-
ments in diabetic patients without signs of peripheral arte-
rial disease compared with age- and sex-matched nondia-
betic patients without signs of peripheral arterial disease.
The main finding of our study was a significantly lower
TcPO2 value measured at both the foot and chest for
diabetic patients compared with nondiabetic patients.
Many studies about TcPO2 and diabetes have been
published since the 1970s. To our knowledge, however, no
studies have been reported in which the study design was to
assess a reference value for TcPO2 in diabetic patients. What
we do know is that impaired tissue oxygenation is an
independent risk factor for diabetic foot ulceration.25,26
Therefore, consistent reference values for TcPO2 in the
diabetic population are crucial to identify patients with a
foot at risk. A previous study showed that TcPO2 measure-
ment is also a useful diagnostic modality to prevent periph-
eral vascular disease in diabetic patients because it detects
early changes in skin oxygenation before the development
of clinically overt microangiopathy.27
In our study we found that when the nondiabetic
patients were compared with patients with type 2 diabetes,
the values for TcPO2 measured at both the dorsum of the
foot and chest wall were significantly lower. However, the
absolute differences of TcPO2values at both the dorsum of
the foot and chest wall between nondiabetic patients and
patients with type 1 diabetes did not reach statistical signif-
icance. An explanation could be the difference in number:
25 type 1 diabetic patients were compared with 35 type 2
diabetic patients.
Next, because we found conflicting studies in the liter-
Fig 3. The correlation of transcutaneous oxygen tensio
measured at the (A) chest wall and the (B) dorsum of thature on the effects of age and sex on TcPO2results,
17,28,29we matched our patient groups for age and sex. Further-
more, in our study cigarette smoking and BMI showed no
association with lower TcPO2 values, which is consistent
with the findings by Rooke et al17 but contrasts with a study
by Strauss et al,30 who identified that cigarette smoking
cessation improved the TcPO2value measured at the foot.
Despite our results, however, the controversy about the
effect of cigarette smoking and BMI on TcPO2 remains.
Further, we also investigated the interobserver variabil-
ity in TcPO2 measurement. No significant absolute differ-
ences were noted between observers. For measurements at
foot and chest level, TcPO2 values obtained by both observ-
ers simultaneously showed a highly significant correlation.
Although variation in the measurements was present, dis-
tribution of error was low and randomly assigned across the
range of values for TcPO2, meaning that the biologic vari-
ance was relatively small. Presented as an ICC value, the
interobserver variability showed a substantial correlation
for measurements at the chest and at the dorsum of the
foot. The ICC value in our study was somewhat smaller
compared with the reported ICC value of 0.77 by De
Graaff et al,31 but was identically classified.
The lower ICC value for the TcPO2 measurements
obtained at the dorsum of the foot compared with the chest
may be explained by the position of the electrodes. Al-
though the electrodes were attached to the first intermeta-
tarsal space as instructed, skin oxygenation could have been
influenced by skin thickness and partially positioning the
electrode on the metatarsal bony or tendon structures,
which may have introduced some variation in our measure-
ments. Overall, the influence of the examiner on the vari-
ance in TcPO2measurements appeared to be relatively
O2) values is shown between observer 1 and 2 for values
t.n (TcPsmall.
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 2 de Meijer et al 387Several possible limitations of this study warrant con-
sideration. First, by using a cross-sectional design, we are
unable to infer causality because the study was done at one
time point without follow-up.
Second, because we only provided a snapshot of the
situation at one specific point in time, results might be
different if another timeframe were chosen. We did not
perform repeated measurements, which have previously
been shown to introduce greater variability.31 Our data
from the interobserver variability analysis, however,
showed a substantial correlation between the measure-
ments taken by both observers at the same time.
Third, because the toe pressure measurements in our
first 20 diabetic patients were in the normal range (unpub-
lished data), neither in the subsequently included diabetic
patients nor in the nondiabetic patients has the diagnosis of
peripheral arterial disease been excluded by additional test-
ing. All patients had bilateral palpable pedal pulses, and all
passed standard neurosensory testing. Onemay rather favor
to have baseline values of toe blood pressures or ankle-
brachial pressure indexes, or both, to objectively exclude
any evidence of peripheral arterial disease; however, these
modalities may often lack discriminative accuracy and do
not reflect local microvascular perfusion status.
This study was designed in such a way that we relied on
the patient’s medical history in addition to a comprehensive
interview and a routine physical examination to provide a
representative sample of patients which physicians daily
encounter in clinical practice.
CONCLUSION
Our results demonstrate that diabetic patients without
signs of peripheral arterial disease and neuropathy have
significantly lower TcPO2 values at both the dorsum of the
foot and the chest wall compared with matched nondia-
betic patients. The reduced supply of oxygen to the skin in
diabetic patients reflects an early subclinical impairment in
their microcirculation, thus providing the TcPO2 measure-
ment as an additional tool in the diagnostic armamentar-
ium of vascular surgeons to assess peripheral vascular dis-
ease in diabetic patients.
We thank Karin Goederaad and Willeke Dolman, vas-
cular technologists, for performing TcPO2 measurements,
and the patients for their voluntary participation in the
study.
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